May 31 (Reuters) - Neuren Pharmaceuticals Ltd NEU.AX
* announces grant of two new patents for Trofinetide to 2032
* Says granted of two new patents in United States and Europe concerning use of Trofinetide to treat autism spectrum disorders Source text for Eikon: Further company coverage: NEU.AX